oncolytics biotech is a biotechnology company focused on the development of oncolytic viruses as potential therapeutics for use in a broad range of cancers. the company is conducting clinical studies using reolysin®, its proprietary formulation of the huma

Oncolytics Biotech, Inc. Common Shares

Bought 15% more ONCY

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Anthony Buonopane

Bought 25% more ONCY

Bought 23% more ONCY

Bought 13% more ONCY

Bought 5% more ONCY

Bought 10% more ONCY

Bought 33% more ONCY

Sold all ONCY

Elisa Esteves

Sold 57% of ONCY

Lemuel

Sold 50% of ONCY

New position in ONCY

Bought 100% more ONCY

Adeleon3

Sold 52% of ONCY

Bought 146% more ONCY